NEW YORK (GenomeWeb News) – The UK's biggest biomedical research funders are starting to get serious about making the results from science they have paid for more widely and easily available by expanding and strengthening their open-access policies.

The Research Councils UK and the Wellcome Trust are leading a movement toward enhanced open-access policies, developing new plans to expand availability of the results of the science that they fund and to increase compliance with those policies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.